Literature DB >> 17218263

Structural basis of integrin activation by talin.

Kate L Wegener1, Anthony W Partridge, Jaewon Han, Andrew R Pickford, Robert C Liddington, Mark H Ginsberg, Iain D Campbell.   

Abstract

Regulation of integrin affinity (activation) is essential for metazoan development and for many pathological processes. Binding of the talin phosphotyrosine-binding (PTB) domain to integrin beta subunit cytoplasmic domains (tails) causes activation, whereas numerous other PTB-domain-containing proteins bind integrins without activating them. Here we define the structure of a complex between talin and the membrane-proximal integrin beta3 cytoplasmic domain and identify specific contacts between talin and the integrin tail required for activation. We used structure-based mutagenesis to engineer talin and beta3 variants that interact with comparable affinity to the wild-type proteins but inhibit integrin activation by competing with endogenous talin. These results reveal the structural basis of talin's unique ability to activate integrins, identify an interaction that could aid in the design of therapeutics to block integrin activation, and enable engineering of cells with defects in the activation of multiple classes of integrins.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17218263     DOI: 10.1016/j.cell.2006.10.048

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  301 in total

1.  Subcellular localization of talin is regulated by inter-domain interactions.

Authors:  Asoka Banno; Benjamin T Goult; HoSup Lee; Neil Bate; David R Critchley; Mark H Ginsberg
Journal:  J Biol Chem       Date:  2012-02-18       Impact factor: 5.157

Review 2.  Spatial organization of adhesion: force-dependent regulation and function in tissue morphogenesis.

Authors:  Ekaterina Papusheva; Carl-Philipp Heisenberg
Journal:  EMBO J       Date:  2010-08-18       Impact factor: 11.598

3.  Ancient origin of the integrin-mediated adhesion and signaling machinery.

Authors:  Arnau Sebé-Pedrós; Andrew J Roger; Franz B Lang; Nicole King; Iñaki Ruiz-Trillo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

4.  Talin-dependent integrin activation is required for fibrin clot retraction by platelets.

Authors:  Jacob R Haling; Susan J Monkley; David R Critchley; Brian G Petrich
Journal:  Blood       Date:  2010-10-22       Impact factor: 22.113

5.  Phosphorylation of Trask by Src kinases inhibits integrin clustering and functions in exclusion with focal adhesion signaling.

Authors:  Danislav S Spassov; Ching Hang Wong; Natalia Sergina; Deepika Ahuja; Michael Fried; Dean Sheppard; Mark M Moasser
Journal:  Mol Cell Biol       Date:  2010-12-28       Impact factor: 4.272

Review 6.  Recent advances in the understanding of the molecular mechanisms regulating platelet integrin αIIbβ3 activation.

Authors:  Lanlan Tao; Yue Zhang; Xiaodong Xi; Nelly Kieffer
Journal:  Protein Cell       Date:  2010-07-29       Impact factor: 14.870

Review 7.  Mammary gland ECM remodeling, stiffness, and mechanosignaling in normal development and tumor progression.

Authors:  Pepper Schedin; Patricia J Keely
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

8.  A talin mutant that impairs talin-integrin binding in platelets decelerates αIIbβ3 activation without pathological bleeding.

Authors:  Lucia Stefanini; Feng Ye; Adam K Snider; Kasra Sarabakhsh; Raymond Piatt; David S Paul; Wolfgang Bergmeier; Brian G Petrich
Journal:  Blood       Date:  2014-02-28       Impact factor: 22.113

9.  The structure of Rap1 in complex with RIAM reveals specificity determinants and recruitment mechanism.

Authors:  Hao Zhang; Yu-Chung Chang; Mark L Brennan; Jinhua Wu
Journal:  J Mol Cell Biol       Date:  2013-11-28       Impact factor: 6.216

10.  Migfilin, a molecular switch in regulation of integrin activation.

Authors:  Sujay Subbayya Ithychanda; Mitali Das; Yan-Qing Ma; Keyang Ding; Xiaoxia Wang; Sudhiranjan Gupta; Chuanyue Wu; Edward F Plow; Jun Qin
Journal:  J Biol Chem       Date:  2008-12-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.